TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Recipharm AB
Closing information (x1000 NOK)
Closing information | 2022/12 | 2021/12 | 2020/12 (consolidated) |
Turnover | 563,230 | 241,732 | 11,595,482 |
Financial expenses | 3,242,919 | 1,597,182 | 562,772 |
Earnings before taxes | -19,946 | 76,856 | 522,125 |
EBITDA | -166,861 | -242,470 | 2,043,556 |
Total assets | 27,913,303 | 16,937,864 | 22,667,792 |
Current assets | 3,759,869 | 2,434,628 | 6,343,856 |
Current liabilities | 2,000,099 | 1,621,819 | 3,522,141 |
Equity capital | 17,011,576 | 6,891,674 | 7,704,795 |
- share capital | 47,823 | 49,305 | 35,514 |
Employees (average) | 67 | 64 | 7,857 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 (consolidated) |
Solvency | 60.9% | 40.7% | 34.0% |
Turnover per employee | 8,406 | 3,777 | 1,476 |
Profit as a percentage of turnover | -3.5% | 31.8% | 4.5% |
Return on assets (ROA) | 11.5% | 9.9% | 4.8% |
Current ratio | 188.0% | 150.1% | 180.1% |
Return on equity (ROE) | -0.1% | 1.1% | 6.8% |
Change turnover | 328,763 | -10,552,612 | 3,783,413 |
Change turnover % | 140% | 48% | |
Chg. No. of employees | 3 | -7,793 | 2,541 |
Chg. No. of employees % | 5% | 48% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.